Genetic therapies for Huntington’s disease, what does the future hold for neurodegenerative disorders?
Sarah Tabrizi · University College London
Antisense oligonucleotide
2 items · last seminar 9 Mar 2021
2 results
Newest first
Seminar1
2021
ePoster1
FENS 2024
miR-145 depletion promotes myelin regeneration in a novel mouse model of multiple sclerosis
Monique Marylin Alves de Almeida, Yves De Repentigny, Emma Sutton et al.